Jürgen Wieland
Development Environmental Sustainability Lead
Novartis Pharma AG, Basel
Novartis has set ambitious environmental sustainability targets to achieve carbon neutral own operations by 2025, carbon & plastic neutrality and water sustainability across the value chain by 2030, and net-zero by 2040.
Jürgen’s role as Environmental Sustainability Lead for Development covers the set-up and execution of low carbon clinical trials and the company wide target of “all new products meet sustainable design principles by 2030”. Novartis was awarded end 2023 by the Sustainable Markets Initiative (SMI) with the “Terra Carta Seal” for their “Greener Clinical Trials” program.
Jürgen has been very engaged and passionate about the topic of Environmental Sustainability for more than three decades. Prior joining Novartis in 2011, he was the CFO of the NGO “Solar Energy Foundation”, supporting the roll-out of solar energy in rural East Africa. From 2015-2020, he was the Finance Head of Novartis’ Global Clinical Supply unit. Jürgen contributes beyond Novartis within the UK based Sustainable Healthcare Coalition to the industries’ low carbon clinical trial workstream and is the Novartis representative in the “Digital Health” workstream of the SMI Health Systems Task Force.